Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

In the PLATelet inhibition and patient Outcomes (PLATO) study of patients with acute coronary syndromes, ticagrelor reduced mortality compared to clopidogrel but the mechanisms for this mortality reduction remain uncertain. We analysed adverse events (AEs) consistent with either pulmonary infection...

詳細記述

保存先:
書誌詳細
出版年:Platelets
主要な著者: Storey, Robert F., James, Stefan K., Siegbahn, Agneta, Varenhorst, Christoph, Held, Claes, Ycas, Joseph, Husted, Steen E., Cannon, Christopher P., Becker, Richard C., Steg, Ph Gabriel, Åsenblad, Nils, Wallentin, Lars
フォーマット: Artigo
言語:Inglês
出版事項: Informa UK Ltd. 2014
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4220996/
https://ncbi.nlm.nih.gov/pubmed/24127651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/09537104.2013.842965
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料